Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, February 22, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
admin
-
February 3, 2025
Latest Pharma-News
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
admin
-
February 3, 2025
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
EMA validates marketing authorisation application for Jemperli plus chemotherapy for dMMR/MSI-H primary advanced or recurrent endometrial cancer
admin
-
April 25, 2023
0
Latest Pharma-News
FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines
admin
-
April 21, 2023
0
Latest Pharma-News
Bayer’s New data from pivotal studies with aflibercept 8 mg
admin
-
April 21, 2023
0
Latest Pharma-News
FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation
admin
-
April 19, 2023
0
Latest Pharma-News
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
admin
-
April 11, 2023
0
Latest Pharma-News
FDA Accepts Pfizer’s sNDA for BRAFTOVI + MEKTOVI
admin
-
April 10, 2023
0
Latest Pharma-News
Sandoz receives approval by EC for Hyrimoz® high-concentration formulation
admin
-
April 6, 2023
0
Latest Pharma-News
AZ’s Lynparza and Imfinzi combination shows positive results in advanced ovarian cancer
admin
-
April 6, 2023
0
Latest Pharma-News
FDA Moves Forward with Mail-back Envelopes for Opioid Analgesics Dispensed in Outpatient Settings
admin
-
April 6, 2023
0
Latest Pharma-News
Ultomiris recommended for approval in EU for neuromyelitis optica spectrum disorder
admin
-
April 3, 2023
0
Latest Pharma-News
FDA Approves First Over-the-Counter Naloxone Nasal Spray
admin
-
March 30, 2023
0
Latest Pharma-News
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
admin
-
March 30, 2023
0
1
2
3
4
...
145
Page 3 of 145
- Advertisment -
Most Read
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
February 10, 2025
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
February 3, 2025
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
February 3, 2025
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025